Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

Tevimbra is under clinical development by BeiGene and currently in Phase I for Adenoid Cystic Carcinoma (ACC).

参考资料： [1]Charles V Clark， Brian Pentland， David J Ewing， Basil F Clarke; Decreased Skin Wrinkling in Diabetes Mellitus. Diabetes Care 1 May 1984; 7 (3)： 224–227. [2]Kamran， H.， ...

Whether you are dealing with severe consequences of cystic fibrosis or want to get ahead the symptoms, these tips will help.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Allison Angell, the first person in the UK to have all of her major organs transplanted, has died aged 46—more than a decade ...

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

The Boomer and Gunnar Esiason Story," detailing a remarkable father-son journey of perseverance and resilience.

The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

Holden McCoy, an eighth grader with cystic fibrosis, was recently a junior starter for the Dallas Stars — a memory he will ...